Cencora, Inc. (COR) Interest Coverage Ratio: 8.69x
The interest coverage ratio for Cencora, Inc. (COR) is 8.69x as of Saturday, June 13, 2026.
COR Interest Coverage Ratio Metrics
INTEREST COVERAGE RATIO
8.69x
COR Competitors' Interest Coverage Ratio
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Cencora, Inc. (COR) | $54.80B | 8.69x | N/A | N/A | N/A |
| Becton, Dickinson and Company (BDX) | $52.98B | 4.21x | 4.38x | 4.79x | 4.28x |
| Regeneron Pharmaceuticals, Inc. (REGN) | $63.06B | 81.69x | 77.00x | 76.06x | 87.20x |
| Humana Inc. (HUM) | $45.53B | 2.30x | 2.38x | 5.10x | 7.90x |
| IDEXX Laboratories, Inc. (IDXX) | $44.24B | 35.54x | 35.85x | 30.16x | 28.81x |
| Agilent Technologies, Inc. (A) | $36.67B | 13.21x | 14.36x | 15.54x | 14.94x |
| Zoetis Inc. (ZTS) | $33.36B | 14.80x | 14.41x | 13.27x | 12.34x |
| Centene Corporation (CNC) | $32.19B | -11.24x | 4.28x | 3.30x | 3.63x |
| Medline Inc. (MDLN) | $30.96B | N/A | 1.38x | 1.23x | 1.23x |
| Cigna Corporation (CI) | $78.83B | 6.61x | 6.58x | 6.49x | 6.37x |
Financial Health Indicators
Interest Coverage
8.7x
Debt/Equity
7.13
Current Ratio
0.90
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
- < 1.5x: EBIT is less than 1.5 times interest expense
- 1.5x - 3x: EBIT is between 1.5 and 3 times interest expense
- 3x - 5x: EBIT is between 3 and 5 times interest expense
- > 5x: EBIT is more than 5 times interest expense
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Cencora, Inc. Interest Coverage Ratio Formula & Definition
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Cencora, Inc. Interest Coverage Ratio FAQ
- What is the interest coverage ratio for Cencora, Inc. (COR)?
- The interest coverage ratio for COR stock is 8.69x.
About Cencora, Inc.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting. It develops and implements supply management software, provides packaging services for both institutional and retail healthcare settings, and assists with clinical trial support, post-market approval processes, and commercialization strategies. For biotechnology and pharmaceutical manufacturers, the company delivers data analytics, outcomes research, and other specialized services. Furthermore, Cencora serves the animal health market, providing pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients for both companion and production animals. It also offers sales force support to manufacturers and specialized services to medical professionals, particularly oncologists, as well as to hospitals and dialysis clinics. The International Healthcare Solutions division concentrates on global pharmaceutical wholesale activities, associated services, and worldwide commercialization support. It ensures the efficient distribution of medicines, various healthcare goods, and related services to an international customer base comprising pharmacies, doctors, health centers, and hospitals. This segment also delivers specialized transportation and logistics solutions specifically designed for the biopharmaceutical sector. Founded in 1871, the company was formerly known as AmerisourceBergen Corporation before adopting the name Cencora, Inc. in August 2023. Its corporate headquarters are situated in Conshohocken, Pennsylvania.
- Sector
- Healthcare
- Industry
- Medical - Distribution
- CEO
- Robert Mauch